Magnusson, M. K., Dahlén, R., Strid, H., Isaksson, S., Simrén, M., Lasson, A., . . . Öhman, L. (2013). CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis. SAGE Publications.
Chicago Style CitationMagnusson, Maria K., Rahil Dahlén, Hans Strid, Stefan Isaksson, Magnus Simrén, Anders Lasson, Antal Bajor, Kjell-Arne Ung, and Lena Öhman. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
MLA CitationMagnusson, Maria K., et al. CD25 and TNF Receptor II Reflect Early Primary Response to Infliximab Therapy in Patients With Ulcerative Colitis. SAGE Publications, 2013.
Warning: These citations may not always be 100% accurate.